Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sabyasachi Ghosh, Ian Smith, James Davidson, Tao Fan, Ninfa Candela, Cynthia Tsang, Troy Koch & Jason Fehr. (2023) Payer-Addressable Burden of Crohn’s Disease in Members Treated with Biologics in the United States: Actuarial Analysis Findings from RAINBOW. North American Actuarial Journal 27:4, pages 619-629.
Read now
Read now
Marco Vincenzo Lenti & Christian P. Selinger. (2017) Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions. Expert Review of Gastroenterology & Hepatology 11:3, pages 215-226.
Read now
Read now
Articles from other publishers (11)
Mafalda Santiago, Cláudia Camila Dias, Catarina Alves, Paula Ministro, Raquel Gonçalves, Diana Carvalho, Francisco Portela, Luís Correia, Paula Lago & Fernando Magro. (2022) The Magnitude of Crohn’s Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review. Inflammatory Bowel Diseases 28:10, pages 1527-1536.
Crossref
Crossref
Dominic Pilon, Zhijie Ding, Erik Muser, Ameur M Manceur, Maude Vermette-Laforme, Marie-Hélène Lafeuille & Patrick Lefebvre. (2022) Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents. Crohn's & Colitis 360 4:3.
Crossref
Crossref
Jean-Frédéric Colombel, Geert D’haens, Wan-Ju Lee, Joel Petersson & Remo Panaccione. (2020) Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review. Journal of Crohn's and Colitis 14:2, pages 254-266.
Crossref
Crossref
Katie Lloyd, Stamatia Papoutsopoulou, Emily Smith, Philip Stegmaier, Francois Bergey, Lorna Morris, Madeleine Kittner, Hazel England, Dave Spiller, Mike H. R. White, Carrie A. Duckworth, Barry J. Campbell, Vladimir Poroikov, Vitor A. P. Martins dos Santos, Alexander Kel, Werner Muller, D. Mark Pritchard, Chris Probert & Michael D. Burkitt. (2020) Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease. Disease Models & Mechanisms.
Crossref
Crossref
Nisha B Shah, Jacob A Jolly, Sara N Horst, Megan Peter, Heather Limper & Autumn D Zuckerman. (2019) Development of quality measures for use of self-injectable biologic therapy in inflammatory bowel disease: An integrated specialty pharmacy initiative. American Journal of Health-System Pharmacy 76:17, pages 1296-1304.
Crossref
Crossref
Shahnaz Khan, Ewa Rupniewska, Mackenzie Neighbors, David Singer, Joseph Chiarappa & Camilo Obando. (2019) Real‐world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic review. Journal of Clinical Pharmacy and Therapeutics.
Crossref
Crossref
Byron P. Vaughn. 2018. Treatment of Inflammatory Bowel Disease with Biologics. Treatment of Inflammatory Bowel Disease with Biologics
33
48
.
Kevin A. Hommel, Meghan E. McGrady, James Peugh, George Zacur, Katherine Loreaux, Shehzad Saeed, Elizabeth Williams & Lee A. Denson. (2017) Longitudinal Patterns of Medication Nonadherence and Associated Health Care Costs. Inflammatory Bowel Diseases 23:9, pages 1577-1583.
Crossref
Crossref
Darren K. Tiao, Webber Chan, Jayson Jeganathan, Jenny T. Chan, Jonathan Perry, Christian P. Selinger & Rupert W. Leong. (2017) Inflammatory Bowel Disease Pharmacist Adherence Counseling Improves Medication Adherence in Crohnʼs Disease and Ulcerative Colitis. Inflammatory Bowel Diseases 23:8, pages 1257-1261.
Crossref
Crossref
Pierre Michetti, John Weinman, Ulrich Mrowietz, Josef Smolen, Laurent Peyrin-Biroulet, Edouard Louis, Dieter Schremmer, Namita Tundia, Pascal Nurwakagari & Nicole Selenko-Gebauer. (2016) Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study. Advances in Therapy 34:1, pages 91-108.
Crossref
Crossref
Y. Kimura, R. Shimada-Omori, T. Takahashi, K. Tsuchiyama, Y. Kusakari, K. Yamasaki, R. Nishikawa, C. Nishigori & S. Aiba. (2016) Therapeutic drug monitoring of patients with psoriasis during tumour necrosis factor (TNF)-α antagonist treatment using a novel interleukin-8 reporter cell line. British Journal of Dermatology 175:5, pages 979-987.
Crossref
Crossref